From at-risk to recognition: improving detection of MASH
Chairs: Lise Lotte Gluud (DNK), Harpreet Bajaj (CAN) 17:00 – 17:17 Spotlight on MASH: navigating early detection in the clinic Lise Lotte Gluud (DNK) Harpreet Bajaj (CAN) 17:17 – 17:27 Enabling action in real-world care: audience Q&A Lise Lotte Gluud (DNK) Harpreet Bajaj (CAN) 17:27 – 17:30 Final reflections and key takeaways Lise Lotte Gluud (DNK) Harpreet Bajaj […]
The evolving role of GLP-1RAs for holistic cardiovascular, kidney, liver and metabolic care
Chair: Steven Kahn (USA) 17:45 – 17:50 Welcome and introduction Steven Kahn (USA) 17:50 – 18:05 Stepping up holistic care: incretin-based and novel combination therapies in obesity John Wilding (GBR) 18:05 – 18:20 Taking the next step: the role of GLP-1RAs in the CKD and T2D nexus Paola Fioretto (ITA) 18:20 – 18:35 At the […]
The impact of COVID-19 on individuals with cardiometabolic diseases: A call to action
Chair: Robert Krause (AUT) 17:45 – 17:53 Welcome and introduction Robert Krause (AUT) 17:53 – 18:08 The interplay of COVID-19 and cardiometabolic diseases Gillian Booth (CAN) 18:08 – 18:23 The importance of staying up-to-date with vaccinations for individuals with cardiometabolic diseases Robert Krause (AUT) 18:23 – 18:38 Integrating COVID-19 vaccination into care pathways for cardiometabolic […]
A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration
Chair: Michael Roden (DEU) 17:45 – 17:55 The Growing Burden of MASLD/MASH: A Call to Action, New Treatments Are Coming Michael Roden (DEU) 17:55 – 18:10 Need to Improve Screening and Diagnosis in Patients with Diabetes Michael Trauner (AUT) 18:10 – 18:25 Changing the MASH Paradigm with THR-β Agonists and Other Disease-specific Therapies Amalia Gastaldelli […]
The missing link: optimising partnerships and communication between endocrinologists and other specialties
Chair: Alice Cheng (CAN) 17:45 – 17:50 Establishing a connection: addressing the relationship between cardio, renal and metabolic conditions Alice Cheng (CAN) 17:50 – 18:05 Stepping into the clinic: Patient case study Pam Kushner (USA) 18:05 – 18:25 Closing the loop: taking SGLT2 inhibitors from evidence into clinical practice All faculty 18:25 – 18:35 Don’t […]
The Value of Real-World Data in Diabetes Technology: Viewpoints from the Diabetes Community
12:30 – 13:00 The Value of Real-World Data in Diabetes Technology: Viewpoints from the Diabetes Community Jackie Elliott (GBR)Rob Malcolm (GBR)John Pemberton (GBR)Andrei Stroila (ROU) Friday, 19 September 2025 12:30 – 13:00 CEST Spotlight Stage
Unlocking Potential: The MiniMed™ 780G System in Type 2 Diabetes
Chair: Ohad Cohen (CHE) 16:00 – 16:15 Glycemic outcomes with MiniMed™ 780G system in people living with type 2 diabetes Ohad Cohen (CHE) 16:15 – 16:30 Diabetes and renal failure: glycemic management with the MiniMed™ 780G system Kirsten Nørgaard (DNK) Wednesday, 17 September 2025 16:00 – 16:30 CEST Arena
Rewriting the script – Novel patient pathways and quality of care in autoimmune T1D
16:00 – 16:05 Why current pathways have become obsolete? Lucien Engelen (NLD) 16:05 – 16:15 Co-creation of novel pathways via collaboration between primary and specialty care Naresh Kanumili (GBR) Steve Edelman (USA) 16:15 – 16:25 New standards of quality of care and experience Korey Hood (USA)Shara Bialo (USA) 16:25 -16:30 Q&A Wednesday, 17 September 2025 […]
Beyond MDI: Why CGM Belongs in Every Type 2 Diabetes Care Plan
Chair: Stefano Del Prato (ITA) 11:00 – 11:30 Beyond MDI: Why CGM Belongs in Every Type 2 Diabetes Care Plan Emma Wilmot (GBR)Virginia Bellido (ESP) Friday, 19 September 2025 11:00 – 11:30 CEST Spotlight Stage
Redefining Success in Obesity Management
Chair: Rachel Batterham (GBR) 17:00 – 17:30 Redefining Success in Obesity Management Arya M. Sharma (DEU)Rachel Batterham (GBR) Thursday, 18 September 2025 17:00 – 17:30 CEST Spotlight Stage